Hemoglobina glicosilada como signo de alarma

Authors

  • Manuel Martín-Regidor Servicio de Medicina Interna, Complejo Asistencial Universitario de León, León, Spain
  • Nakaire Bonache-Castejón Servicio de Medicina Interna, Complejo Asistencial Universitario de León, León, Spain
  • María Esther Fernández-Pérez Servicio de Medicina Interna, Complejo Asistencial Universitario de León, León, Spain
  • Ana Martínez-Alonso Servicio de Medicina Interna, Complejo Asistencial Universitario de León, León, Spain
  • Gerard Sancho-Pascual Servicio de Medicina Interna, Complejo Asistencial Universitario de León, León, Spain

DOI:

https://doi.org/10.32818/reccmi.a4s1a5

Keywords:

glycosylated hemoglobin, general syndrome, pancreatic cancer

Abstract

A 67-year-old woman with type 2 diabetes, who after several years of good glycemic control with HbA1c around 6.5%, consulted for cardinal symptoms with polyuria, weight loss and asthenia. The initial blood test shows HbA1c 14%, which is why it is decided to extend studies. A pancreatic mass is evidently found in MR cholangiography, which after carrying out echoendoscopy with biopsies confirms the presence of an anaplastic adenocarcinoma of the pancreas.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Muniraj T, Chari ST. Diabetes and pancreatic cancer. Minerva Gastroenterol Dietol. 2012 Dec;58(4):331-45.

Andersen DK, Korc M, Petersen GM, Eibl G, Li D, Rickels MR et al. Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer. Diabetes. 2017 May;66(5):1103-1110. doi: https://doi.org/10.2337/db16-1477.

Published

2019-01-31

How to Cite

1.
Martín-Regidor M, Bonache-Castejón N, Fernández-Pérez ME, Martínez-Alonso A, Sancho-Pascual G. Hemoglobina glicosilada como signo de alarma. Rev Esp Casos Clin Med Intern [Internet]. 2019 Jan. 31 [cited 2024 Jul. 22];4:11-3. Available from: https://www.reccmi.com/RECCMI/article/view/340

Similar Articles

You may also start an advanced similarity search for this article.